Oil & Gas Exploration & Production
Build Your Comparison
Side-by-side financial analysisStock Comparison
VIVK vs CHNR vs JPM vs RCON vs BAC
Revenue, margins, valuation, and 5-year total return — side by side.
Waste Management
Banks - Diversified
Oil & Gas Equipment & Services
Banks - Diversified
VIVK vs CHNR vs JPM vs RCON vs BAC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Oil & Gas Exploration & Production | Waste Management | Banks - Diversified | Oil & Gas Equipment & Services | Banks - Diversified |
| Market Cap | $599.00 | $42M | $908.57B | $10M | $424.14B |
| Revenue (TTM) | $87M | $0.00 | $280.33B | $66M | $191.57B |
| Net Income (TTM) | $-107M | $-14M | $57.05B | $-43M | $30.51B |
| Gross Margin | 44.7% | — | 60.0% | 23.0% | 56.1% |
| Operating Margin | -22.2% | — | 25.9% | -86.5% | 19.7% |
| Forward P/E | 16.9x | — | 14.6x | — | 12.6x |
| Total Debt | $35M | $0.00 | $942.38B | $34M | $365.90B |
| Cash & Equiv. | $265K | $3M | $343.34B | $99M | $231.84B |
VIVK vs CHNR vs JPM vs RCON vs BAC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Vivakor, Inc. (VIVK) | 100 | 0.0 | -100.0% |
| China Natural Resou… (CHNR) | 100 | 9.0 | -91.0% |
| JPMorgan Chase & Co. (JPM) | 100 | 345.8 | +245.8% |
| Recon Technology, L… (RCON) | 100 | 2.4 | -97.6% |
| Bank of America Cor… (BAC) | 100 | 236.6 | +136.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: VIVK vs CHNR vs JPM vs RCON vs BAC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
VIVK is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 16.3%, EPS growth -109.2%, 3Y rev CAGR 54.9%
- 16.3% revenue growth vs CHNR's -100.0%
- Beta 0.65 vs CHNR's 1.54
CHNR lags the leaders in this set but could rank higher in a more targeted comparison.
JPM carries the broadest edge in this set and is the clearest fit for long-term compounding and bank quality.
- 481.2% 10Y total return vs BAC's 371.6%
- NIM 2.2% vs BAC's 1.8%
- 20.4% margin vs VIVK's -124.0%
- 1.8% yield, 15-year raise streak, vs BAC's 2.3%, (3 stocks pay no dividend)
RCON is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.76, Low D/E 7.6%, current ratio 5.88x
BAC ranks third and is worth considering specifically for income & stability and valuation efficiency.
- Dividend streak 12 yrs, beta 0.83, yield 2.3%
- PEG 0.82 vs JPM's 0.83
- Beta 0.83, yield 2.3%, current ratio 0.42x
- Better valuation composite
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 16.3% revenue growth vs CHNR's -100.0% | |
| Value | Better valuation composite | |
| Quality / Margins | 20.4% margin vs VIVK's -124.0% | |
| Stability / Safety | Beta 0.65 vs CHNR's 1.54 | |
| Dividends | 1.8% yield, 15-year raise streak, vs BAC's 2.3%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +27.2% vs VIVK's -100.0% | |
| Efficiency (ROA) | 1.3% ROA vs VIVK's -68.1%, ROIC 4.5% vs -13.1% |
VIVK vs CHNR vs JPM vs RCON vs BAC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
VIVK vs CHNR vs JPM vs RCON vs BAC — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
JPM leads in 3 of 6 categories
VIVK leads 0 • CHNR leads 0 • RCON leads 0 • BAC leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM and CHNR operate at a comparable scale, with $280.3B and $0 in trailing revenue. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to VIVK's -124.0%. On growth, RCON holds the edge at +2.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $87M | $0 | $280.3B | $66M | $191.6B |
| EBITDAEarnings before interest/tax | -$5M | -$12M | $81.4B | -$54M | $40.0B |
| Net IncomeAfter-tax profit | -$107M | -$14M | $57.0B | -$43M | $30.5B |
| Free Cash FlowCash after capex | -$19M | -$6M | $100.9B | -$44M | $12.6B |
| Gross MarginGross profit ÷ Revenue | +44.7% | — | +60.0% | +23.0% | +56.1% |
| Operating MarginEBIT ÷ Revenue | -22.2% | — | +25.9% | -86.5% | +19.7% |
| Net MarginNet income ÷ Revenue | -124.0% | — | +20.4% | -64.3% | +15.9% |
| FCF MarginFCF ÷ Revenue | -22.1% | — | +36.0% | -65.9% | +6.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | -47.9% | — | — | +2.6% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +100.0% | +91.3% | +16.0% | +35.7% | +18.3% |
Valuation Metrics
Evenly matched — VIVK and JPM and BAC each lead in 2 of 7 comparable metrics.
Valuation Metrics
At 14.7x trailing earnings, BAC trades at a 9% valuation discount to JPM's 16.2x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.92x vs BAC's 0.96x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $599 | $42M | $908.6B | $10M | $424.1B |
| Enterprise ValueMkt cap + debt − cash | $35M | $41M | $1.51T | $503,161 | $558.2B |
| Trailing P/EPrice ÷ TTM EPS | 0.00x | -88.11x | 16.22x | -0.72x | 14.71x |
| Forward P/EPrice ÷ next-FY EPS est. | 16.86x | — | 14.60x | — | 12.60x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.92x | — | 0.96x |
| EV / EBITDAEnterprise value multiple | — | — | 18.52x | — | 13.95x |
| Price / SalesMarket cap ÷ Revenue | 0.00x | — | 3.25x | 1.02x | 2.21x |
| Price / BookPrice ÷ Book value/share | 0.00x | 3.19x | 2.51x | 0.07x | 1.40x |
| Price / FCFMarket cap ÷ FCF | — | — | 9.01x | — | 33.63x |
Profitability & Efficiency
JPM leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-184 for VIVK. RCON carries lower financial leverage with a 0.08x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), BAC scores 7/9 vs CHNR's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -184.2% | -15.7% | +15.9% | -9.2% | +10.1% |
| ROA (TTM)Return on assets | -68.1% | -5.3% | +1.3% | -8.0% | +0.9% |
| ROICReturn on invested capital | -13.1% | -0.0% | +4.5% | -10.6% | +3.5% |
| ROCEReturn on capital employed | -25.9% | -0.0% | +8.9% | -11.8% | +4.5% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 2 | 5 | 4 | 7 |
| Debt / EquityFinancial leverage | 0.95x | — | 2.60x | 0.08x | 1.21x |
| Net DebtTotal debt minus cash | $35M | -$3M | $599.0B | -$64M | $134.1B |
| Cash & Equiv.Liquid assets | $265,019 | $3M | $343.3B | $99M | $231.8B |
| Total DebtShort + long-term debt | $35M | $0 | $942.4B | $34M | $365.9B |
| Interest CoverageEBIT ÷ Interest expense | -2.83x | -263.29x | 0.74x | -372.30x | 0.48x |
Total Returns (Dividends Reinvested)
JPM leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $23,548 today (with dividends reinvested), compared to $0 for VIVK. Over the past 12 months, BAC leads with a +27.2% total return vs VIVK's -100.0%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.7% vs VIVK's -97.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -99.9% | +22.2% | +0.8% | -67.6% | +1.4% |
| 1-Year ReturnPast 12 months | -100.0% | +4.9% | +20.9% | -80.5% | +27.2% |
| 3-Year ReturnCumulative with dividends | -100.0% | -74.0% | +138.8% | -93.1% | +105.5% |
| 5-Year ReturnCumulative with dividends | -100.0% | -92.6% | +135.5% | -99.3% | +57.4% |
| 10-Year ReturnCumulative with dividends | -100.0% | -92.3% | +481.2% | -99.5% | +371.6% |
| CAGR (3Y)Annualised 3-year return | -97.8% | -36.2% | +33.7% | -58.9% | +27.1% |
Risk & Volatility
Evenly matched — VIVK and BAC each lead in 1 of 2 comparable metrics.
Risk & Volatility
VIVK is the less volatile stock with a 0.65 beta — it tends to amplify market swings less than CHNR's 1.54 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BAC currently trades 96.9% from its 52-week high vs VIVK's 0.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.65x | 1.54x | 0.87x | 0.76x | 0.83x |
| 52-Week HighHighest price in past year | $52000.00 | $8.20 | $338.09 | $7.16 | $57.98 |
| 52-Week LowLowest price in past year | $0.01 | $3.16 | $269.72 | $0.49 | $44.21 |
| % of 52W HighCurrent price vs 52-week peak | +0.0% | +52.4% | +96.2% | +7.0% | +96.9% |
| RSI (14)Momentum oscillator 0–100 | 30.1 | 47.5 | 72.1 | 31.5 | 70.9 |
| Avg Volume (50D)Average daily shares traded | 2.7M | 93K | 7.4M | 39K | 32.4M |
Analyst Outlook
Evenly matched — JPM and BAC each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: JPM as "Buy", BAC as "Buy". Consensus price targets imply 8.8% upside for BAC (target: $61) vs 4.5% for JPM (target: $340). For income investors, BAC offers the higher dividend yield at 2.25% vs JPM's 1.83%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Buy | — | Buy |
| Price TargetConsensus 12-month target | — | — | $339.75 | — | $61.13 |
| # AnalystsCovering analysts | — | — | 61 | — | 54 |
| Dividend YieldAnnual dividend ÷ price | — | — | +1.8% | — | +2.3% |
| Dividend StreakConsecutive years of raises | 1 | 0 | 15 | 1 | 12 |
| Dividend / ShareAnnual DPS | — | — | $5.95 | — | $1.27 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +3.8% | 0.0% | +5.1% |
JPM leads in 3 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 3 categories are tied.
VIVK vs CHNR vs JPM vs RCON vs BAC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is VIVK or CHNR or JPM or RCON or BAC a better buy right now?
For growth investors, Vivakor, Inc.
(VIVK) is the stronger pick with 16. 3% revenue growth year-over-year, versus -3. 7% for Recon Technology, Ltd. (RCON). Bank of America Corporation (BAC) offers the better valuation at 14. 7x trailing P/E (12. 6x forward), making it the more compelling value choice. Analysts rate JPMorgan Chase & Co. (JPM) a "Buy" — based on 61 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — VIVK or CHNR or JPM or RCON or BAC?
On trailing P/E, Bank of America Corporation (BAC) is the cheapest at 14.
7x versus JPMorgan Chase & Co. at 16. 2x. On forward P/E, Bank of America Corporation is actually cheaper at 12. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Bank of America Corporation wins at 0. 82x versus JPMorgan Chase & Co. 's 0. 83x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — VIVK or CHNR or JPM or RCON or BAC?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +135. 5%, compared to -100. 0% for Vivakor, Inc. (VIVK). Over 10 years, the gap is even starker: JPM returned +481. 2% versus VIVK's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — VIVK or CHNR or JPM or RCON or BAC?
By beta (market sensitivity over 5 years), Vivakor, Inc.
(VIVK) is the lower-risk stock at 0. 65β versus China Natural Resources, Inc. 's 1. 54β — meaning CHNR is approximately 136% more volatile than VIVK relative to the S&P 500. On balance sheet safety, Recon Technology, Ltd. (RCON) carries a lower debt/equity ratio of 8% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — VIVK or CHNR or JPM or RCON or BAC?
By revenue growth (latest reported year), Vivakor, Inc.
(VIVK) is pulling ahead at 16. 3% versus -3. 7% for Recon Technology, Ltd. (RCON). On earnings-per-share growth, the picture is similar: China Natural Resources, Inc. grew EPS 95. 9% year-over-year, compared to -109. 2% for Vivakor, Inc.. Over a 3-year CAGR, VIVK leads at 54. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — VIVK or CHNR or JPM or RCON or BAC?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 20. 4% net margin versus -105. 6% for Vivakor, Inc. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus -86. 5% for RCON. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is VIVK or CHNR or JPM or RCON or BAC more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Bank of America Corporation (BAC) is the more undervalued stock at a PEG of 0. 82x versus JPMorgan Chase & Co. 's 0. 83x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Bank of America Corporation (BAC) trades at 12. 6x forward P/E versus 16. 9x for Vivakor, Inc. — 4. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BAC: 8. 8% to $61. 13.
08Which pays a better dividend — VIVK or CHNR or JPM or RCON or BAC?
In this comparison, BAC (2.
3% yield), JPM (1. 8% yield) pay a dividend. VIVK, CHNR, RCON do not pay a meaningful dividend and should not be held primarily for income.
09Is VIVK or CHNR or JPM or RCON or BAC better for a retirement portfolio?
For long-horizon retirement investors, JPMorgan Chase & Co.
(JPM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 87), 1. 8% yield, +481. 2% 10Y return). China Natural Resources, Inc. (CHNR) carries a higher beta of 1. 54 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (JPM: +481. 2%, CHNR: -92. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between VIVK and CHNR and JPM and RCON and BAC?
These companies operate in different sectors (VIVK (Energy) and CHNR (Industrials) and JPM (Financial Services) and RCON (Energy) and BAC (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: VIVK is a small-cap high-growth stock; CHNR is a small-cap quality compounder stock; JPM is a large-cap deep-value stock; RCON is a small-cap quality compounder stock; BAC is a large-cap deep-value stock. JPM, BAC pay a dividend while VIVK, CHNR, RCON do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.